Alpine Peaks Capital, LP - Q2 2022 holdings

$85.7 Million is the total value of Alpine Peaks Capital, LP's 24 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
IPAR BuyINTER PARFUMS INC$6,119,000
-7.6%
83,749
+11.3%
7.14%
+4.7%
BFAM BuyBRIGHT HORIZONS FAM SOL IN D$4,779,000
-0.1%
56,539
+56.9%
5.58%
+13.3%
TRMB BuyTRIMBLE INC$4,454,000
-16.2%
76,483
+3.8%
5.20%
-5.0%
WST BuyWEST PHARMACEUTICAL SVSC INC$4,319,000
-15.1%
14,283
+15.3%
5.04%
-3.7%
CGNX BuyCOGNEX CORP$4,107,000
-28.2%
96,600
+30.4%
4.79%
-18.5%
SYNH BuySYNEOS HEALTH INCcl a$3,939,000
+3.6%
54,953
+17.0%
4.60%
+17.5%
MEDP BuyMEDPACE HLDGS INC$3,877,000
+0.4%
25,906
+9.7%
4.52%
+13.8%
ROL BuyROLLINS INC$3,021,000
+51.2%
86,500
+51.8%
3.52%
+71.4%
QLYS BuyQUALYS INC$2,744,000
-2.5%
21,750
+10.1%
3.20%
+10.6%
RHI BuyROBERT HALF INTL INC$2,314,000
+2.9%
30,901
+56.8%
2.70%
+16.7%
HEIA BuyHEICO CORP NEWcl a$2,018,000
+5.0%
19,150
+26.4%
2.36%
+19.1%
NSP BuyINSPERITY INC$1,717,000
+12.5%
17,200
+13.2%
2.00%
+27.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTER PARFUMS INC8Q3 20238.2%
WEST PHARMACEUTICAL SVSC INC8Q3 20236.7%
COGNEX CORP8Q3 20236.2%
U S PHYSICAL THERAPY8Q3 20235.8%
WABTEC8Q3 20235.7%
MEDPACE HLDGS INC8Q3 20236.4%
TRIMBLE INC8Q3 20235.5%
BRIGHT HORIZONS FAM SOL IN D8Q3 20235.6%
SERVICE CORP INTL8Q3 20235.3%
AMPHENOL CORP NEW8Q3 20235.3%

View Alpine Peaks Capital, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR/A2022-11-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14

View Alpine Peaks Capital, LP's complete filings history.

Export Alpine Peaks Capital, LP's holdings